about
A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune CheckpointsSystemic treatment for advanced hepatocellular carcinoma: the search of new agents to join sorafenib in the effective therapeutic armamentarium.Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy.Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma.Acute liver failure caused by pembrolizumab in a patient with pulmonary metastatic liver cancer: A case report.Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic.
P2860
Q26738729-E67455C0-9839-414A-B4DF-8C03F00AB333Q38824017-F8EDFFEA-D29C-40C6-916E-D9209E342D88Q40282288-A4DD131E-7378-45F3-8DFE-50E003FC3B86Q47169813-F1B424B6-CCF3-4F9E-948A-E567C339848EQ49294620-CC3BC7E0-8483-412D-ABAB-2B2CAB2515B0Q49479055-592D6EB5-80CA-47F3-8B86-DEE15000144CQ54518660-1F50DFD4-9F61-45C3-8B2A-749284A9F359
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pembrolizumab: A Review in Advanced Melanoma.
@en
type
label
Pembrolizumab: A Review in Advanced Melanoma.
@en
prefLabel
Pembrolizumab: A Review in Advanced Melanoma.
@en
P2860
P1433
P1476
Pembrolizumab: A Review in Advanced Melanoma.
@en
P2093
Emma D Deeks
P2860
P2888
P304
P356
10.1007/S40265-016-0543-X
P577
2016-02-04T00:00:00Z
P6179
1052306527